Current Report Filing (8-k)
14 Juin 2022 - 11:01PM
Edgar (US Regulatory)
false 0000876378 0000876378 2022-06-14
2022-06-14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
June 14, 2022
Date of Report (date of earliest event reported)
_________________
Asensus Surgical, Inc.
(Exact name of Registrant as specified in its charter)
_________________
|
Delaware |
|
0-19437 |
|
11-2962080 |
|
(State or other jurisdiction of incorporation or
organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
1 TW Alexander Drive, Suite 160
Durham, NC 27703
(Address of principal executive offices)
919-765-8400
(Registrant’s telephone number, including area
code)
Not Applicable
(Former name or former address, if changed since last
report)
_________________
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
|
Trading symbol
|
|
Name of each exchange on which registered
|
|
Common Stock
$0.001 par value per share
|
|
ASXC
|
|
NYSE American
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
|
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
On June 14, 2022, Asensus Surgical, Inc. (the “Company”) held its
2022 Annual Meeting of Stockholders (the “Annual Meeting”). At the
Annual Meeting, the total number of shares represented in person or
by proxy was 111,427,690.75 of the 236,415,789 shares of Common
Stock outstanding and entitled to vote at the Annual Meeting as of
the record date, April 18, 2022. The following matters were voted
upon at the Annual Meeting:
1. Election of Directors. The
following named persons were elected as Directors of the Company to
serve until the next Annual Meeting of Stockholders in 2023 or
until their successors are elected and qualified. The votes cast
were as follows:
|
Director Nominee |
|
|
For |
|
|
|
Vote Withheld |
|
|
|
|
|
|
|
|
|
|
|
|
David B. Milne
|
|
|
37,965,825.90 |
|
|
|
13,271,415.95 |
|
|
Anthony Fernando
|
|
|
41,427,918.77 |
|
|
|
9,809,322.08 |
|
|
Andrea Biffi
|
|
|
43,152,531.64 |
|
|
|
8,084,709.21 |
|
|
Kevin Hobert
|
|
|
48,001,657.21 |
|
|
|
3,235,584.64 |
|
|
Elizabeth Kwo
|
|
|
47,964,808.81 |
|
|
|
3,272,432.03 |
|
|
Richard C. Pfenniger, Jr.
|
|
|
38,251,791.83 |
|
|
|
12,985,449.02 |
|
|
William N. Starling
|
|
|
40,201,628.69 |
|
|
|
11,035,613.16 |
|
There were 60,190,448.89 broker non-votes for this proposal.
2. Say on Pay. The stockholders
voted to approve, on an advisory basis, the compensation of the
Company’s named executive officers for 2021, as described in the
proxy statement for the Annual Meeting in accordance with
Regulation S-K, Item 402. The stockholder vote was as
follows:
|
|
27,882,377.59 Votes
|
|
FOR the resolution
|
|
|
|
22,296,247.89 Votes
|
|
AGAINST the resolution
|
|
|
|
1,058,615.36 Votes
|
|
ABSTAIN
|
|
There were 60,190,449.89 broker non-votes for this proposal.
3. Ratification of Independent Public
Accounting Firm for 2022. The stockholders voted to ratify
the appointment of BDO USA, LLP as the independent registered
public accounting firm for the Company for the year ending December
31, 2022. The stockholder vote was as follows:
|
|
108,294,852.77 Votes
|
|
FOR the resolution
|
|
|
|
2,068,290.47 Votes
|
|
AGAINST the resolution
|
|
|
|
1,064,547.49 Votes
|
|
ABSTAIN
|
|
There were no broker non-votes for this proposal.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
| |
ASENSUS SURGICAL, INC. |
| |
|
| Date: June 14, 2022 |
/s/ Shameze
Rampertab |
| |
Shameze Rampertab |
| |
Executive Vice President and Chief Financial Office |
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Déc 2022 à Jan 2023
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Jan 2022 à Jan 2023
